Q2 SOLUTIONS
LIVE

Serial Number

86680061

Owner

Q Squared Solutions Holdings LLC

Attorney

Arlene D. Hanks

First Use Date

Jul 2, 2015

Filing Date

Jul 1, 2015

Add to watchlist:

No watchlists yet
View on USPTO

Q2 SOLUTIONS Trademark

Serial Number: 86680061 • Registration: 5251668

Q2 SOLUTIONS is a trademark filed by Q Squared Solutions Holdings LLC on July 1, 2015. The trademark is classified under Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Q Squared Solutions Holdings LLC (2 trademarks)

2400 Ellis Road
Durham, NC 27703

Entity Type: 16

Trademark Details

Filing Date

July 1, 2015

Registration Date

July 25, 2017

First Use Anywhere

July 2, 2015

First Use in Commerce

July 2, 2015

Published for Opposition

October 4, 2016

Goods & Services

Providing health and medical information; providing pharmaceutical information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; providing medical information relating to pharmacogenomics and biomarkers; health management and disease management medical information to others; medical evaluation services; medical consulting services in the fields of health care, medicine, life sciences, and pharmaceuticals, biopharmaceuticals, biomarkers, pharmacogenomics, medical device and diagnostics; providing an online interactive computer database in the field of healthcare featuring healthcare information; providing an Internet website portal featuring medical and healthcare information in the fields of medical services, health care, health management and disease management; providing an online searchable database via the internet featuring medical and healthcare information in the fields of medical services, medical devices and diagnostics, health care, health management and disease management; none of the foregoing for use in the field of Medicare

[ Educational and training services, namely, conducting training programs, seminars, classes, conferences and workshops in the fields of health policy, health management, and disease management, patient management, and pharmaceutical, pharmacogenomic, biomarker, medical device and diagnostics, and distributing course materials in connection therewith; teaching and training in information technology for the healthcare industry; all of the foregoing relating to clinical trials, clinical research, medical and scientific laboratory services, biopharmaceutical, biomarker, diagnostics and medical product and device development, and research, testing, regulatory approval and commercialization of diagnostics, biopharmaceuticals, biomarkers and medical products and devices and none of the foregoing for use in the field of or related to Medicare or other governmental health programs ]

Computerized database management and data processing services in the pharmaceutical, pharmacogenomic, biomarker, biopharmaceutical, medical device and diagnostics fields; providing business information, namely, information related to regulatory approval and marketing of drugs, devices, health care or medical products and services, and biologics; business research in the field of health care; business consultation in the field of healthcare; business technology consulting, namely, business consulting services relating to the integration of the areas of business process technology, change management and operational sustainability in the healthcare, medical, health management and disease management fields; none of the foregoing for use in the field of Medicare

[ Computer software for providing, managing and analyzing laboratory clinical trial data and laboratory and clinical trials information in the fields of pharmaceutical, pharmacogenomic, biomarker, biopharmaceutical, medical device and diagnostics, life sciences, medical, health care, health management and disease management fields; computer software that allows remote access to clinical trial laboratory data and laboratory and clinical trials information; computer software for use in collecting and reporting medical data relating to patient medical conditions for clinical trials, research, peri- and post-approval studies, quality improvement, and patient support programs; none of the foregoing for use in the field of Medicare ]

Regulatory compliance research and consulting services in the fields of health care, clinical trials, development and testing of drugs, devices, biologics and methodologies used in the pharmaceutical industry, biotechnology industry and the medical device and diagnostics industry; conducting regulatory compliance audits for others in the fields of health care, clinical trials, pharmaceutical, pharmacogenomic, biomarker, biopharmaceutical, and medical device and diagnostics; consulting services in the fields of regulatory affairs, namely, regulatory compliance consulting in the field of prescription drug sampling; manufacturing compliance and validation procedures, namely, reviewing standards and practices to assure compliance with clinical trial regulations, medical and laboratory testing services; providing regulatory information, namely, providing regulatory compliance information regarding the examination and approval process of pharmaceutical, biotechnical, medical and diagnostic products and methodologies by governmental regulatory bodies; providing regulatory compliance consulting services relating to the development and validation of drugs, devices and biologics, namely, assisting others in implementing procedures that comply with regulatory requirements; none of the foregoing for use in the field of Medicare

Clinical research and testing services, in the fields of clinical trials, health care products, pharmaceutical products, pharmacogenomics products, biomarker products, biopharmaceutical products, medical devices and diagnostics products; product development consultation in the fields of health care, medical products and devices; health care research and product development services; medical and laboratory testing services for research purposes; laboratory testing services for research purposes in the fields of health care, clinical trials, pharmaceutical, pharmacogenomics, biomarker, biopharmaceutical, medical device and diagnostics; consultancy in the design, planning and implementation project management of clinical trials; health care medical research consultancy; product development consultancy in the fields of medical diagnostics, medical devices, pharmacology, pharmacogenomics, biomarkers and biopharmaceutical research; managing, namely, monitoring, coordinating and implementing clinical studies being clinical trials on human subjects for others for research purposes; medical and scientific research in the fields of healthcare and medical diagnostics; providing temporary use of non-downloadable, web-based software application for providing access to information and data in the clinical trials, pharmaceutical, pharmacogenomic, biomarker, biopharmaceutical, medical device and diagnostics, life sciences, health management and disease management fields and for organizing and analyzing said data and information and preparing reports therefrom, providing temporary use of non-downloadable software for providing, managing and analyzing laboratory clinical trial data and information in the fields of pharmaceutical, pharmacogenomic, biomarker, biopharmaceutical, medical device and diagnostics, life sciences, health management and disease management fields; providing temporary use of non-downloadable software that allows remote access to clinical trial peri- and post-approval laboratory data and information; providing temporary use of non-downloadable software for use in collecting and reporting medical data relating to patient medical conditions for research; providing scientific and medical research information relating to the development and validation of drugs, pharmaceutical products, medical products, medical devices and biologics; providing an internet website portal featuring scientific and medical research information in the fields of clinical trials, pharmaceutical research, pharmacogenomic and biomarker consultation, biopharmaceutical consultation, medical devices and diagnostics, life sciences research, and medical research; providing an online searchable database via the internet featuring medical and scientific research information in the fields of clinical trials, companion diagnostics, pharmaceutical research, pharmacogenomic and biomarkers, biopharmaceuticals, medical devices and diagnostics, life sciences research, and medical research; all of the foregoing relating to clinical trials, clinical research, medical and scientific laboratory services, biopharmaceutical, biomarker, diagnostics and medical product and device development, and research, testing, regulatory approval and commercialization of diagnostics, biopharmaceuticals, biomarkers and medical products and devices and none of the foregoing for use in the field of or related to Medicare or other governmental health programs

Filing History

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Jul 25, 2026 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Aug 10, 2024 NA85
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Aug 10, 2024 C15P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 10, 2024 APRE
TEAS SECTION 8 & 15 RECEIVED
Jan 25, 2024 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jul 25, 2022 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 18, 2018 TCCA
REGISTERED-PRINCIPAL REGISTER
Jul 25, 2017 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jun 21, 2017 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jun 20, 2017 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jun 6, 2017 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 6, 2017 AITU
USE AMENDMENT FILED
May 10, 2017 IUAF
TEAS STATEMENT OF USE RECEIVED
May 10, 2017 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 29, 2016 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 4, 2016 NPUB
PUBLISHED FOR OPPOSITION
Oct 4, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 14, 2016 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 29, 2016 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 23, 2016 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 18, 2016 XAEC
ASSIGNED TO LIE
Aug 17, 2016 ALIE
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 17, 2016 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 17, 2016 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 17, 2016 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
May 9, 2016 GNFN
FINAL REFUSAL E-MAILED
May 9, 2016 GNFR
FINAL REFUSAL WRITTEN
May 9, 2016 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 16, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 15, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 15, 2016 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Oct 20, 2015 GPRN
PRIORITY ACTION E-MAILED
Oct 20, 2015 GPRA
PRIORITY ACTION WRITTEN
Oct 20, 2015 CPRA
ASSIGNED TO EXAMINER
Oct 12, 2015 DOCK
NOTICE OF PSEUDO MARK E-MAILED
Jul 8, 2015 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 7, 2015 NWOS
NEW APPLICATION ENTERED
Jul 4, 2015 NWAP